As found in "The Bull". Go half way down the article.
Simon Hermann, wise-owl.com
http://www.thebull.com.au/premium/a/58757-18-share-tips---14-march-2016.html
This is what he said about Acrux:
"Sales in 2015 of its flagship product Axiron, a testosterone replacement therapy, missed our expectations. We believe future sales may not meet our targets. We advised to sell in 2015 and retain our advice. While ACR may present a speculative opportunity, we would want to see more encouraging data and a technical reversal of its stock before upgrading our view."
I should not be bashing this stock. I wish I could think of a counter positive argument. As @mwilson25 said: what are the management saying? Actually what are they doing? Can anyone can anything that will counter what Simon Hermann. I do not want "Simon is a complete $#@$#@$" or "Simon is an absolute genius, etc etc". He is a professional and he is entitled to promote his opinion. I just want a positive counter argument.
- Forums
- ASX - By Stock
- ACR
- Sell Recommendation by Simon Herrmann, wise-owl.com
Sell Recommendation by Simon Herrmann, wise-owl.com
-
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACR (ASX) to my watchlist
|
|||||
Last
6.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.89M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3903 | 6.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.4¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3903 | 0.062 |
2 | 116666 | 0.060 |
1 | 17200 | 0.058 |
2 | 167543 | 0.057 |
2 | 67857 | 0.056 |
Price($) | Vol. | No. |
---|---|---|
0.064 | 100000 | 1 |
0.065 | 70395 | 1 |
0.070 | 50000 | 1 |
0.072 | 47301 | 1 |
0.073 | 30000 | 3 |
Last trade - 16.12pm 12/07/2024 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
Day chart unavailable